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ABSTRACT 
Synovial sarcomas are highly aggressive soft tissue tumour with a poor and dismal 
prognosis. These tumours have a high propensity for distant metastasis and local 
recurrence.  Although originally believed to arise from synovium, these tumours have 
been found to occur anywhere in body [1],[2]. We report here, a case of median nerve 
sarcoma in a 15-year female. This is a rare tumour, which is diagnosed only after 
histopathological examination with only a few cases reported in the literature (Table 
1). Although preoperatively tumour was thought to be a nerve sheath tumour, on 
histopathology analysis was found to be synovial sarcoma. Despite aggressive 
behaviour, wide local excision is recommended even in smaller lesions. So, the 
diagnosis should always be kept in differentials of nerve sheath tumour, as what may 
be a synovial sarcoma. 
 
 
INTRODUCTION 
Synovial sarcomas may arise from different and unusual sites with 
distinctive morphological genetic features [3]. They are mostly seen in 
extremities in young adolescents with male preponderance [4]. It has 
been found in unusual locations in heart, lung, small intestine, soft 
palate and peripheral nerves. Only a few cases have been reported in 
peripheral nerve. Prognosis is poor despite radical surgery, radiation 
and chemotherapy with 50-60 % survival [5]. 
These sarcomas have origin in synovium because of periarticular 
location, but less than 5% are continuous with synovium4. Sarcomas 
have their origin from primitive mesenchymal undifferentiated cells6. 
Synovial sarcoma is diagnosed on immunohistochemical basis because 
most of them present as lump or swelling with no clinical or diagnostic 
features [7]. Translocation (X;18) is diagnostic in 90% of cases [8]. The 
case presented here is a rare sarcoma arising from median nerve in 
upper arm. We have described here clinical, radiological features and 
its management. 
 
CASE PRESENTATION 
A 15 years old female presented with swelling in left arm for last 6 
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months with swelling of size of 5*4 cm in left arm 
which has gradually increased in size. She also 
complained of pain in left arm radiating along medial 
aspect of forearm up to left hand. The pain was 
sharp, and more during night. She also complained 
of tingling sensation in left upper limb, palm, index 
and thumb and had history of dropping objects from 
left hand. On examination, there was decreased 
sensation along radial three digits with no 
neurovascular deficit.  
The patient was evaluated with Magnetic 
resonance imaging (Figure 1) which revealed a well 
encapsulated oval lesion in left upper arm medially 
burrowing in left biceps and coracobrachialis muscle. 
The lesion minimally indented the left brachial 
artery. The lesion was in continuity with median 
nerve which showed mild enhancement in early and 
late arterial phase with heterogenous enhancement 
with non-enhancing / cystic areas in venous and 
delayed phase. Overall findings were in favour of 
neurogenic tumour. 
 
 
 
Figure 1.  
 
Electrodiagnostic studies and nerve conduction 
studies of median nerve were within normal limits. 
Ultrasound colour Doppler peripheral venous single 
upper limb was suggestive of hetero-echoic lesion 
with internal cystic components measuring 43*23 
mm causing compression of underlying axillary 
artery medially at its lower margin. The patient was 
taken up for surgical resection with preservation of 
nerve fascicles. The mass found to be associated 
intimately associated with nerve, soft in consistency 
and moderately vascular in nature. Microvsacular 
excision of mass was done with preservation of 
nerve fascicles (Figure 2). 
On histopathological analysis, tumour was 
greyish tan made up of spindle cells with sheets of 
cells with vesicular nuclei and ill-defined cell margins 
suggestive of mild epitheloid morphology (Figure 3). 
Focal areas showed perivascular arrangement with 
cells separated by blood vessels with occasional 
mitosis and areas of haemorrhage. Collagen and 
osseous tissue was seen adjacent to tumour. On 
immunohistochemistry CD 99 was positive, CK 
negative, Synaptophysin negative, S-100 negative, 
HMB-45 negative, BCL2 positive and Ki-67 was 15-20 
% in cellular areas (Figure 4). The histopathological 
and immunohistochemical analysis were in favour of 
synovial sarcoma. Post operatively, whole body 
PET/CECT scan was done for any metastasis and 
restaging. This was suggestive of small minimally 
metabolic active solid soft tissue thickening in 
proximal left biceps muscle indenting left brachial 
artery probably? residual lesion. Post excision, 
patient received radiotherapy. 
 
Figure 2.  
 
 
 
 
Figure 3.  
 277 Intraneural synovial sarcoma of median nerve 
 
 
Figure 4.  
 
DISCUSSION 
Synovial sarcomas arising from median nerve are 
very rare and rarest tumours published in literature. 
Other sarcomas arising from various nerves 
reported in literature are from radial, common 
digital, posterior tibialis, peroneal, facial nerve, S1 
root, C7 root and brachial plexus. There are three 
basic histology features of synovial sarcoma. The 
most common pattern is biphasic followed by 
monophasic and poorly differentiated synovial 
sarcomas. Synovial sarcoma with biphasic type 
consisted of epithelial cells with fibroblast like 
spindle cell in various proportions. Monophasic type 
consists of spindle cells only and are difficult to 
differentiate from other soft tissue and nerve 
tumours but now can be differentiated on the basis 
of immunohistochemical analysis4. Third pattern of 
poorly differentiated synovial sarcomas that has 
worse prognosis and has also been described6. 
Prognosis of biphasic versus monophasic is still 
under debate9,10,11,12. 
The present case in our study was biphasic 
synovial sarcoma having both epithelial and spindle 
cells in various proportions. It was 
immunohistochemical positive for CD99 and bcl2. 
The neoplastic proliferation with characteristic SS18-
SSX1 with chromosomal fusion at molecular level is 
a feature consistent with diagnosis with synovial 
sarcoma4. Patient was advised for chromosomal 
analysis, but due to financial constraints patient 
refused for same. Published cases of median nerve 
synovial sarcoma with review of literature is 
summarised in table 1 and table 2 respectively. 
Chromosomal translocation is the most efficient 
way to establish the diagnosis of synovial sarcoma. A 
gene translocation between chromosomes 18 and X 
t(x;18) (p11.2; q11.2) occurs in over 90% of synovial 
sarcomas4. This leads to fusion of one of two variants 
of the SSX gene with the SYT gene, resulting in either 
the SYT/SSX1 or SYT/SSX2 chimeric fusion proteins4,6. 
Nearly all biphasic tumours express SYT/SSX1, while 
monophasic tumours express SYT/SSX1 in 
approximately half of the cases and SYT/SSX2 in the 
remainder13. Patients with SYT/SSX2 expressing 
tumours have a significantly better prognosis when 
compared to those with SYT/SSX1 tumours in terms 
of rates of metastasis and overall survival13,14,15,16. 
 Factors associated with poor prognosis includes old 
age, tumour size more than 5 cm, bone, nerve and 
vascular invasion and poor differentiation with 
higher mitotic index 12,17,18,19.Management of synovial 
sarcoma is wide surgical excision, radiation therapy, 
and adjuvant chemotherapy which has been found 
to be correlated to be associated with better 
prognosis2,20  
 
 
 
Surgical management followed by radiation and 
chemotherapy is associated with good prognosis2,20. 
5-year survival rates of synovial sarcomas have been 
around 50-60%, in spite of advances in 
treatment2,21,22. Mortality in synovial sarcoma results 
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from distant metastasis, most frequently to lung23. 
Radical surgical incision followed by radiation 
allowed for potential decrease in local recurrence 
but systemic metastasis remained high even with 
adjunct chemotherapy24. 
 
CONCLUSION 
Synovial sarcoma involving median nerve is a rare 
and aggressive tumour and is one of the few cases 
already published in literature. Synovial sarcoma can 
occur anywhere in our body and should be kept in 
differentials involving peripheral nerves as in our 
case. As diagnosis is always made post operative on 
histo-patholoical analysis with immuno-
histochemistry, resulting in change in treatment 
strategy and final outcome of patient. As in our 
patient, preoperative diagnosis was a benign 
neurofibroma/schwannoma, we must be aware of 
aggressive tumour which overall changes the 
complete treatment and should be always be kept in 
differentials and managed accordingly. 
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